Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-18-000050
Filing Date
2018-05-09
Accepted
2018-05-09 16:48:31
Documents
75
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptct0331201810-q.htm 10-Q 1088682
2 EXHIBIT 31.1 ptct03312018ex-311.htm EX-31.1 14364
3 EXHIBIT 31.2 ptct03312018ex-312.htm EX-31.2 14365
4 EXHIBIT 32.1 ptct03312018ex-321.htm EX-32.1 7318
5 EXHIBIT 32.2 ptct03312018ex-322.htm EX-32.2 7308
  Complete submission text file 0001070081-18-000050.txt   7571133

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptct-20180331.xml EX-101.INS 1744424
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20180331.xsd EX-101.SCH 47166
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20180331_cal.xml EX-101.CAL 74261
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20180331_def.xml EX-101.DEF 355774
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptct-20180331_lab.xml EX-101.LAB 676407
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20180331_pre.xml EX-101.PRE 486409
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 18819036
SIC: 2834 Pharmaceutical Preparations